相关实验视频

Updated: Jul 2, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

在西班牙的一组帕金森病患者中,维生素D受体多态化

Saray Canales-Cortés^1,2, Mario Rodríguez-Arribas^1,2,3, María F Galindo⁴

¹Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Cáceres, Spain.

Genetic testing and molecular biomarkers

|February 28, 2024

概括

维生素D受体 (VDR) BsmI基因多态性与帕金森病 (PD) 的风险增加有关. 在这个西班牙队列中,其他VDR基因变异与PD没有关联.

科学领域:

遗传学遗传学是一个
神经科学是一个神经科学.
内分泌学在内分泌学.

背景情况:

维生素D受体 (VDR) 在黑色物质中至关重要,其缺乏和基因多态性与帕金森病 (PD) 风险有关.
之前的病例控制研究表明VDR和PD之间存在联系,需要对特定基因变异进行进一步调查.

研究的目的:

在西班牙人群中检查VDR基因多态 (ApaI,BsmI,FokI,TaqI) 与帕金森病之间的关联.
确定这些VDR多态是否与PD患者的疾病发病年龄或运动症状相关.

主要方法:

在54名帕金森病患者和17名来自西班牙队列的健康对照组中进行了一项病例控制研究.
在VDR基因中,单核酸多态 (SNP) 使用聚合酶连锁反应-限制片段长度多态 (PCR-RFLP) 进行了鉴定.

主要成果:

在这个队列中,VDR ApaI,FokI和TaqI多态性与帕金森病没有显著的关联.
VDR BsmI 多态性显示出与PD的显著关联,患者的 BsmI 基因型是患者的五倍,A 基因被确定为遗传风险因素.
综合分析显示,FokI和BsmI多态组合与PD有显著的关联,这表明潜在的综合风险因素.

结论:

在研究的西班牙人群中,VDR ApaI,TaqI和FokI多态性与帕金森病风险无关.
在这个队列中,VDR BsmI多态性成为帕金森病的潜在遗传风险因素.
VDR FokI和BsmI多态的联合效应可能代表PD的额外危险因素.

关键词:

这就是BSMIL的意思.在Exon中使用Exon.一个等位基因,一个等位基因.基因型基因型基因型核激素受体是核激素受体的一个组成部分.单个核酸的多形态.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...